Effects of dexamethasone on cerebral perfusion and water diffusion in patients with high-grade glioma

American Journal of Neuroradiology

Volumn 27, Issue 2, 2006, Pages 402-408

  Bastin, Mark E ^a   Carpenter, T K ^a   Armitage, P A ^a   Sinha, S ^a   Wardlaw, J M ^a   Whittle, I R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; WATER; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN EDEMA; BRAIN PERFUSION; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIFFUSION; FEMALE; GLIOBLASTOMA; HUMAN; MALE; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; STATISTICAL SIGNIFICANCE; STUDENT T TEST; WHITE MATTER; BLOOD BRAIN BARRIER; BLOOD FLOW; BLOOD FLOW VELOCITY; BLOOD VOLUME; BRAIN; BRAIN TUMOR; COMPARATIVE STUDY; DIFFUSION WEIGHTED IMAGING; DRUG EFFECT; IMAGE ENHANCEMENT; IMAGE PROCESSING; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VASCULARIZATION;

ADULT; AGED; BLOOD FLOW VELOCITY; BLOOD VOLUME; BLOOD-BRAIN BARRIER; BRAIN; BRAIN EDEMA; BRAIN NEOPLASMS; CONTRAST MEDIA; DEXAMETHASONE; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GADOLINIUM DTPA; GLIOBLASTOMA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; SENSITIVITY AND SPECIFICITY;

EID: 33645742046     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Galicich JH, French LA, Melby JC. Use of dexamethasone in the treatment of cerebral edema associated with brain tumors. Lancet 1961;81:46-53
2. Maxwell RE, Long DM, French LA. The clinical effects of a synthetic glucocorticoid used for brain edema in the practice of neurosurgery. In: Reulen HJ, Schürmann K, eds. Steroids and brain edema. Berlin: Springer-Verlag;1972: 219-32
3. Hossmann KA, Hurter T, Oschlies U. The effect of dexamethasone on serum protein extravasation and edema development in experimental brain tumors of cat. Acta Neuropathol 1983;60:223-31
4. Sinha S, Bastin ME, Wardlaw IM, et al. Effects of dexamethasone on peritumoral oedematous brain: a DT-MRI study. J Neurol Neurosurg Psychiatry 2004; 75:1632-35
5. Østergaard L, Hochberg FH, Rabinov ID, et al. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J Neurosurg 1999;90:300-305
6. Leenders KL, Beaney RP, Brooks DJ, et al. Dexamethasone treatment of brain tumor patients: effects on regional cerebral blood flow, blood volume, and oxygen utilization. Neurology 1985;35:1610-16
7. Reulen HJ, Hadjidimos A, Schürmann K. The effect of dexamethasone on water and electrolyte content and on rCBF in perifocal brain edema in man. In: Reulen HJ, Schürmann K, eds. Steroids and brain edema. Berlin: Springer-Verlag;1972:239-52
8. Van Roost D, Hartmann A, Quade G. Changes of cerebral blood flowfollowing dexamethasone treatment in brain tumor patients. A Xe/CT study. Acta Neurochir 2001;143:37-43
9. Behrens PF, Ostertag CB, Warnke PC. Regional cerebral blood flow in peritumoral brain edema during dexamethasone treatment: a xenon-enhanced computed tomographic study. Neurosurgery 1998;43:235-40
10. Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5:143-56
11. Østergaard L, Sorensen AG, Kwong KK, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II. Experimental comparison and preliminary results. Magn Reson Med 1996;36: 726-36
12. Østergaard L, Weisskoff RM, Chester DA, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I. Mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-25
13. Calamante F, Gadian DG, Connelly A. Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: assumptions, limitations, and potential implications for clinical use. Stroke 2002;33:1146-51
14. Sinha S, Bastin ME, Whittle IR, et al. Diffusion tensor MR imaging of high-grade cerebral gliomas. AJNR Am J Neuroradiol 2002;23:520-27
15. Johnson KM, Tao JZ, Kennan RP, et al. Intravascular susceptibility agent effects on tissue transverse relaxation rates in vivo. Magn Reson Med 2000;44: 909-14
16. Wirestam R, Ryding E, Lindgren A, et al. Absolute cerebral blood flow measured by dynamic susceptibility contrast MRI: a direct comparison with Xe-133 SPECT. MAGMA 2000;11:96-103
17. Carroll TJ, Teneggi V, Jobin M, et al. Absolute quantification of cerebral blood flow with magnetic resonance, reproducibility of the method, and comparison with H2(15)O positron emission tomography. J Cereb Blood Flow Metab 2002;22:1149-56
18. Law M, Yang S, Babb JS, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746-55
19. Akella NS, Twieg DB, Mikkelsen T, et al. Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: quality and analysis results of a phase I trial. J Magn Reson Imaging 2004;20:913-22